← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2005Last known activity
Oct 26, 2023
Timeline
1990s
- Jan 1, 1996
Cancer Trials Ireland— Founded
Drugs by trial phase (49 distinct, 36 trials)
Phase 3 (18 own, 0 via acquisition)
Phase 2 (24 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Bone Marrow Diseases
- Bone Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Renal Cell
- Colorectal Neoplasms
- Esophageal Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Chronic-Phase
- Lung Neoplasms
- Melanoma
- Mesothelioma
- Multiple Myeloma
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Germ Cell and Embryonal
- Neoplasms, Plasma Cell
- Neoplasms, Second Primary
- Pancreatic Neoplasms
- Plasmacytoma
- Prostatic Neoplasms
- Small Cell Lung Carcinoma
- Stomach Neoplasms
Recent trials (39)
- NCT05710666Lead sponsorPhase 2Oct 26, 2023
- NCT05518110Lead sponsorPhase 2Jan 31, 2023
- NCT05123131Lead sponsorPhase 2Dec 15, 2021
- NCT04667663Lead sponsorPhase 1Mar 31, 2021
- NCT04608318CollaboratorPhase 3Dec 31, 2020
- NCT04617067Lead sponsorPhase 2Oct 16, 2020
- NCT04136353CollaboratorPhase 3Jan 31, 2020
- NCT04042051Study directorPhase 1Sep 30, 2019
- NCT04042051Lead sponsorPhase 1Sep 30, 2019
- NCT03869762Lead sponsorPhase 2Jan 9, 2019
- NCT03153280Lead sponsorPhase 1Jun 1, 2017
- NCT02955810CollaboratorPhase 1Nov 1, 2016
- NCT02705859Lead sponsorPhase 1Apr 1, 2016
- NCT02194842CollaboratorPhase 3Oct 1, 2015
- NCT02225704Lead sponsorPhase 2Jun 1, 2015
Details
- Founded
- Dublin, IE Jan 1, 1996
- Last known activity
- Oct 26, 2023